Ductal closure with intravenous paracetamol: a new approach to patent ductus arteriosus treatment

References

• Hammerman C, Bin-Nun A, Kaplan M. Managing the patent ductus arteriosus in the premature neonate: a new look at what we thought we knew. Semin Perinatol 2012;36:130–8
   PubMed Web of Science ®Google Scholar
• Clyman R, Noori S. The very low birth weight neonate with hemodynamically significant ductus arteriosus during the first postnatal week. In: Polin RA, Kleinmann CS, Seri I, eds. Hemodynamics and cardiology. 2nd ed. Philadelphia: Elsevier Saunders; 2012:269–91
   Google Scholar
• Madan JC, Kendrick D, Hagadorn JI, et al. National Institute of Child Health and Human Development Neonatal Research Network. Patent ductus arteriosus therapy: impact on neonatal and 18-month outcome. Pediatrics 2009;123:674–81
   PubMed Web of Science ®Google Scholar
• Koch J, Hensley G, Roy L, et al. Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less. Pediatrics 2006;117:1113–21
   PubMed Web of Science ®Google Scholar
• Hamrick S, Hansmann G. Patent ductus arteriosus of the preterm infant. Pediatrics 2010;125:1020–30
   PubMed Web of Science ®Google Scholar
• Allegaert K, Anderson B, Simons S, van Overmeire B. Paracetamol to induce ductus arteriosus closure: is it valid? Arch Dis Child. 2013;98:462–6
   PubMed Web of Science ®Google Scholar
• Brunner B, Hoeck M, Schermer E, et al. Patent ductus arteriosus low platelets. Cyclooxygenase inhibitors and intraventricular hemorrhage in very low birth weight preterm infants. J Pediatr 2013;163:23–8
   PubMed Web of Science ®Google Scholar
• Hammerman C, Bin-Nun A, Markovitch E, et al. Ductal closure with paracetamol: a surprising new approach to patent ductus arteriosus treatment. Pediatrics 2011;128:e1618–21
   PubMed Web of Science ®Google Scholar
• Oncel MY, Yurttutan S, Degirmencioglu H, et al. Intravenous paracetamol treatment in the management of patent ductus arteriosus in extremely low birth weight infants. Neonatology 2013;103:166–9
   PubMed Web of Science ®Google Scholar
• Yurttutan S, Oncel MY, Arayıcı S, et al. A different first-choice drug in the medical management of patent ductus arteriosus: oral paracetamol. J Matern Fetal Neonatal Med 2013;26:825–7
   PubMed Web of Science ®Google Scholar
• El Hajjar M, Vaksmann G, Rakza T, et al. Severity of the ductal shunt: a comparison of different markers. Arch Dis Child Fetal Neonatal Ed 2005;90:F419–22
   PubMed Web of Science ®Google Scholar
• Hamrick S, Hansmann G. Patent ductus arteriosus of the preterm infant. Pediatrics 2010;125:1020–30
   PubMed Web of Science ®Google Scholar
• Clyman RI. Patent ductus arteriosus in the preterm infant. In: Gleason CA, Devaskar SU, eds. Avery’s diseases of the newborn. 9th ed. Philadelphia: Elsevier Saunders; 2012:751–61
   Google Scholar
• Oncel MY, Yurttutan S, Uras N, et al. An alternative drug (paracetamol) in the management of patent ductus arteriosus in ibuprofen-resistant or contraindicated preterm infants. Arch Dis Child Fetal Neonatal Ed 2013;98:F94
   PubMed Web of Science ®Google Scholar
• Sinha R, Negi V, Dalal SS. An interesting observation of PDA closure with oral paracetamol in preterm neonates. J Clin Neonatol 2013;2:30–2
   PubMedGoogle Scholar
• Ozdemir OM, Dogan M, Kucuktas K, et al. Paracetamol therapy for patent ductus arteriosus in premature infants: a chance before surgical ligation. Pediatr Cardiol 2014;35:276–9
   PubMed Web of Science ®Google Scholar
• Nadir E, Kassem E, Foldi S, et al. Paracetamol treatment of patent ductus arteriosus in preterm infants. J Perinatol 2014;34:748–9
   PubMed Web of Science ®Google Scholar
• Terrin G, Conte F, Scipione A, et al. Efficacy of paracetamol for the treatment of patent ductus arteriosus in preterm neonates. Italian J Pediatrics 2014;40:21–4
   PubMed Web of Science ®Google Scholar
• Roofthooft DW, van Beynum IM, Helbing WA, et al. Paracetamol for ductus arteriosus closure: not always a success story. Concerning the article by M.Y. Oncel et al.: intravenous paracetamol treatment in the management of patent ductus arteriosus in extremely low birth weight infants [Neonatology 2013;103:166–169]. Neonatology 2013;104:170
   PubMed Web of Science ®Google Scholar
• Alan S, Kahvecioglu D, Erdeve O, et al. Is paracetamol a useful treatment for ibuprofen-resistant patent ductus arteriosus? Concerning the article by M.Y. Oncel et al.: intravenous paracetamol treatment in the management of patent ductus arteriosus in extremely low birth weight infants [Neonatology 2013;103:166–169]. Neonatology 2013;104:168–9
   PubMed Web of Science ®Google Scholar
• Tekgunduz KS, Ceviz N, Demirelli Y, et al. Intravenous paracetamol for patent ductus arteriosus in premature infants – a lower dose is also effective. Neonatology 2013;104:6–7
   PubMed Web of Science ®Google Scholar
• El-Khuffash A, Jain A, Corcoran D, et al. Efficacy of paracetamol on patent ductus arteriosus closure may be dose dependent: evidence from human and murine studies. Pediatr Res 2014;76:238–44
   PubMed Web of Science ®Google Scholar
• Aikio O, Härkin P, Saarela T, Hallman M. Early paracetamol treatment associated with lowered risk of persistent ductus arteriosus in very preterm infants. J Matern Fetal Neonatal Med 2014;27:1252–6
   PubMed Web of Science ®Google Scholar
• Dang D, Wang D, Zhang C, et al. Comparison of oral paracetamol versus ibuprofen in premature infants with patent ductus arteriosus: a randomized controlled trial. PLoS One 2013;8:e77888–92
   PubMed Web of Science ®Google Scholar
• Oncel MY, Yurttutan S, Erdeve O, et al. Oral paracetamol versus oral ibuprofen in the management of patent ductus arteriosus in preterm infants: a randomized controlled trial. J Pediatr 2014;164:510–14
   PubMed Web of Science ®Google Scholar